Psyence Biomedical Ltd. shares its Q2 2026 financial results, highlighting key developments in the pharmaceutical preparations sector.
| Name | PSYENCE BIOMEDICAL LTD. |
|---|---|
| CIK | 0001985062 |
| Tickers | PBM, PBMWW |
| Exchanges | Nasdaq, Nasdaq |
| Entity type | other |
| Category | Non-accelerated filer<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 0331 |
| State of incorporation | A6 Ontario, Canada |
| Phone | 27744604171 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Psyence Biomedical Ltd. shares its Q2 2026 financial results, highlighting key developments in the pharmaceutical preparations sector.
Psyence Biomedical Ltd. finalizes a $2.6 million investment in PsyLabs, marking a key milestone in its ibogaine development program.
Psyence Biomedical Ltd. partners with Benuvia Operations to manufacture pharmaceutical-grade ibogaine in the U.S., enhancing production capabilities.
171 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-122017 | 001-41937 | 261572369 | 34 | 3874980 | 1 | 1 | |
| 2026-10-21 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-111174 | 001-41937 | 261474134 | 34 | 35918 | |||
| 2026-10-15 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001213900-26-109613 | 005-94325 | 261461513 | 34 | 26520 | |||
| 2026-10-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000929638-26-003844 | 005-94325 | 261439032 | 34 | 7285 | |||
| 2026-10-05 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106630 | 001-41937 | 261438744 | 34 | 36782 | |||
| 2026-09-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-103733 | 001-41937 | 261411948 | 34 | 115235 | |||
| 2026-09-23 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-102358 | 001-41937 | 261398172 | 34 | 326071 | |||
| 2026-09-14 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-099451 | 001-41937 | 261375814 | 34 | 31920 | |||
| 2026-09-01 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002862 | 333-298570 | 261352531 | 33 | 1851 | ||
| 2026-08-26 | S-8 | REGISTRATION STATEMENT | 0001213900-26-093629 | 333-298571 | 261317192 | 33 | 243630 | 1 | 1 | |
| 2026-08-26 | F-3 | REGISTRATION STATEMENT | 0001213900-26-093628 | 333-298570 | 261317190 | 33 | 437986 | 1 | 1 | |
| 2026-08-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086123 | 001-41937 | 261248711 | 34 | 30015666 | |||
| 2026-06-22 | 20-F | ANNUAL REPORT | 0001213900-26-070607 | 001-41937 | 261106929 | 34 | 8429423 | 1 | 1 | |
| 2026-06-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001376474-26-000435 | 005-94325 | 261079405 | 34 | 6237 | |||
| 2026-06-05 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-065824 | 001-41937 | 261069312 | 34 | 176418 | |||
| 2026-06-03 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001213900-26-064484 | 005-94325 | 261059218 | 34 | 17951 | |||
| 2026-04-23 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-047089 | 001-41937 | 26888829 | 34 | 35099 | |||
| 2026-04-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-045373 | 001-41937 | 26873433 | 34 | 43233 | |||
| 2026-04-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-045238 | 001-41937 | 26872455 | 34 | 28058 | |||
| 2026-04-15 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-043636 | 001-41937 | 26861835 | 34 | 24683 | |||
| 2026-03-02 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-021987 | 001-41937 | 26703441 | 34 | 77612 | |||
| 2026-02-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-018919 | 001-41937 | 26661331 | 34 | 39010 | |||
| 2026-02-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001376474-26-000189 | 005-94325 | 26652617 | 34 | 5922 | |||
| 2026-02-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-018155 | 001-41937 | 26651482 | 34 | 38312 | |||
| 2026-02-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-016391 | 001-41937 | 26632349 | 34 | 160902 | |||
| 2026-02-12 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-015229 | 001-41937 | 26623569 | 34 | 134008 | |||
| 2026-01-29 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-009093 | 001-41937 | 26574565 | 34 | 25562 | |||
| 2026-01-27 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-007899 | 001-41937 | 26561973 | 34 | 23055 | |||
| 2026-01-14 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-004380 | 001-41937 | 26533610 | 34 | 30821 | |||
| 2026-01-13 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001539497-26-000044 | 005-94325 | 26531031 | 34 | 35947 | |||
| 2026-01-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-003680 | 001-41937 | 26528470 | 34 | 26684 | |||
| 2026-01-13 | 6-K/A | CURRENT REPORT | 0001213900-26-003621 | 001-41937 | 26528235 | 34 | 3982285 | |||
| 2026-01-08 | 6-K | CURRENT REPORT | 0001213900-26-002516 | 001-41937 | 26519655 | 34 | 8801573 | |||
| 2025-12-10 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001539497-25-003250 | 005-94325 | 251562990 | 34 | 40414 | |||
| 2025-11-21 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-113704 | 001-41937 | 251509020 | 34 | 31202 | |||
| 2025-11-20 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-113190 | 333-289285 | 251503985 | 33 | 523835 | |||
| 2025-11-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-113106 | 001-41937 | 251502973 | 34 | 4051786 | 1 | 1 | |
| 2025-11-12 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-108740 | 333-289285 | 251469034 | 33 | 26363 | |||
| 2025-11-10 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-108225 | 001-41937 | 251466380 | 34 | 89979 | |||
| 2025-11-03 | 424B3 | PROSPECTUS | 0001213900-25-104933 | 333-289285 | 251442239 | 33 | 1690505 | |||
| 2025-10-14 | F-1/A | AMENDMENT NO. 2 TO FORM F-1 | 0001213900-25-098716 | 333-289285 | 251391777 | 33 | 9004217 | 1 | 1 | |
| 2025-10-09 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-097819 | 001-41937 | 251385271 | 34 | 16735 | |||
| 2025-10-06 | F-1/A | AMENDMENT NO. 1 TO FORM F-1 | 0001213900-25-096665 | 333-289285 | 251377753 | 33 | 9163610 | 1 | 1 | |
| 2025-10-06 | CORRESP | filename1.htm | 0001213900-25-096529 | 6763 | ||||||
| 2025-09-05 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-085011 | 001-41937 | 251296759 | 34 | 109309 | |||
| 2025-08-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-081729 | 001-41937 | 251273335 | 34 | 29291 | |||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008515 | 333-289285 | 43854 | |||||
| 2025-08-06 | F-3 | REGISTRATION STATEMENT | 0001213900-25-072327 | 333-289285 | 251187598 | 33 | 777501 | 1 | 1 | |
| 2025-07-25 | 20-F/A | AMENDMENT NO. 1 TO FORM 20-F | 0001213900-25-067748 | 001-41937 | 251151811 | 34 | 315709 | 1 | 1 | |
| 2025-07-23 | S-8 | REGISTRATION STATEMENT | 0001213900-25-067048 | 333-288905 | 251143911 | 33 | 148652 | |||
| 2025-06-25 | 20-F | ANNUAL REPORT | 0001213900-25-057893 | 001-41937 | 251074496 | 34 | 9171798 | 1 | 1 | |
| 2025-06-25 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-057779 | 001-41937 | 251073586 | 34 | 198257 | |||
| 2025-06-11 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-053433 | 001-41937 | 251039948 | 34 | 313416 | |||
| 2025-05-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-046051 | 001-41937 | 25969958 | 34 | 19535372 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072207 | 005-94325 | 25950437 | 34 | 29050 | |||
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001393825-25-000026 | 005-94325 | 25945002 | 34 | 11618 | |||
| 2025-05-12 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-042029 | 005-94325 | 25934825 | 34 | 14921 | |||
| 2025-05-06 | 6-K | 6-K | 0001213900-25-040150 | 001-41937 | 25917087 | 34 | 20369 | |||
| 2025-04-23 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-034643 | 001-41937 | 25861867 | 34 | 91566 | |||
| 2025-04-11 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-031060 | 001-41937 | 25831478 | 34 | 98854 | |||
| 2025-04-01 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-027251 | 001-41937 | 25800799 | 34 | 37743 | |||
| 2025-03-31 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001013762-25-004459 | 001-41937 | 25788789 | 34 | 862154 | |||
| 2025-03-25 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001013762-25-002278 | 005-94325 | 25769430 | 34 | 14135 | |||
| 2025-03-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000691 | 333-285542 | 25742180 | 33 | 1793 | ||
| 2025-03-13 | CORRESP | filename1.htm | 0001213900-25-023419 | 6824 | ||||||
| 2025-03-11 | UPLOAD | filename1.pdf | 0000000000-25-002652 | 333-285542 | 40117 | |||||
| 2025-03-04 | F-3 | REGISTRATION STATEMENT | 0001213900-25-020258 | 333-285542 | 25705586 | 33 | 1288156 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020385 | 005-94325 | 25623135 | 34 | 28851 | |||
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002033916-25-000025 | 005-94325 | 25607291 | 34 | 11229 | |||
| 2025-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002033916-25-000010 | 005-94325 | 25606738 | 34 | 10248 | |||
| 2025-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000252 | 333-284444 | 25575680 | 33 | 1793 | ||
| 2025-01-30 | 424B3 | 424B3 | 0001410578-25-000062 | 333-284444 | 25574519 | 33 | 3541042 | |||
| 2025-01-28 | CORRESP | filename1.htm | 0001104659-25-006681 | 6023 | ||||||
| 2025-01-28 | UPLOAD | filename1.pdf | 0000000000-25-000884 | 333-284444 | 40130 | |||||
| 2025-01-24 | F-1 | F-1 | 0001410578-25-000041 | 333-284444 | 25551522 | 33 | 17184118 | 1 | 1 | |
| 2025-01-23 | 6-K | 6-K | 0001410578-25-000039 | 001-41937 | 25550069 | 34 | 14006967 | 1 | 1 | |
| 2025-01-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001104659-25-001659 | 021-534475 | 25514817 | 33 | 11203 | ||
| 2025-01-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000929638-25-000041 | 005-94325 | 25512198 | 34 | 6120 | |||
| 2024-12-31 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000017 | 333-283980 | 25500011 | 33 | 1793 | ||
| 2024-12-31 | 424B3 | 424B3 | 0001410578-24-002127 | 333-283980 | 241593312 | 33 | 2842067 | |||
| 2024-12-31 | 6-K | FORM 6-K | 0001104659-24-132846 | 001-41937 | 241592958 | 34 | 905930 | |||
| 2024-12-30 | CORRESP | filename1.htm | 0001104659-24-132289 | 6569 | ||||||
| 2024-12-27 | UPLOAD | filename1.pdf | 0000000000-24-014286 | 333-283980 | 40138 | |||||
| 2024-12-23 | 6-K | FORM 6-K | 0001104659-24-131392 | 001-41937 | 241575045 | 34 | 24718 | |||
| 2024-12-20 | F-1 | F-1 | 0001410578-24-002107 | 333-283980 | 241568162 | 33 | 9519292 | 1 | 1 | |
| 2024-12-19 | 6-K | FORM 6-K | 0001104659-24-129990 | 001-41937 | 241561005 | 34 | 485339 | |||
| 2024-12-18 | 6-K | FORM 6-K | 0001104659-24-129774 | 001-41937 | 241559626 | 34 | 31019 | |||
| 2024-12-13 | SC 13G | SC 13G | 0001193125-24-277985 | 005-94325 | 241546950 | 34 | 34429 | |||
| 2024-12-09 | SC 13G/A | SC 13G/A | 0001193125-24-273261 | 005-94325 | 241534644 | 34 | 117130 | |||
| 2024-12-04 | SC 13G/A | SC 13G/A | 0001193125-24-270735 | 005-94325 | 241526688 | 34 | 115751 | |||
| 2024-12-04 | 6-K | FORM 6-K | 0001104659-24-125352 | 001-41937 | 241524815 | 34 | 19692 | |||
| 2024-12-04 | 6-K | FORM 6-K | 0001104659-24-125346 | 001-41937 | 241524790 | 34 | 77414 | |||
| 2024-12-03 | 6-K | 6-K | 0001104659-24-124932 | 001-41937 | 241521414 | 34 | 48128 | |||
| 2024-11-22 | 6-K | FORM 6-K | 0001104659-24-121840 | 001-41937 | 241486497 | 34 | 8841943 | |||
| 2024-11-13 | SC 13G/A | SC 13G/A | 0001193125-24-256694 | 005-94325 | 241451515 | 34 | 116175 | |||
| 2024-11-12 | 6-K | FORM 6-K | 0001104659-24-116934 | 001-41937 | 241449945 | 34 | 50680 | |||
| 2024-11-12 | SC 13G/A | SC 13G/A | 0001193125-24-255701 | 005-94325 | 241446820 | 34 | 116241 | |||
| 2024-11-12 | SC 13G | sch13g.htm | 0000929638-24-003819 | 005-94325 | 241446666 | 34 | 61759 | |||
| 2024-11-12 | 424B3 | 424B3 | 0001410578-24-001838 | 333-282904 | 241442370 | 33 | 2827568 | |||
| 2024-11-08 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2024-11-08 17:00:00 | 9999999995-24-003434 | 333-282904 | 241442647 | 33 | 1794 | ||
| 2024-11-06 | CORRESP | filename1.htm | 0001104659-24-114781 | 6978 | ||||||
| 2024-11-06 | UPLOAD | filename1.pdf | 0000000000-24-012349 | 333-282904 | 40202 | |||||
| 2024-11-01 | 6-K | FORM 6-K | 0001104659-24-113487 | 001-41937 | 241419131 | 34 | 27065 | |||
| 2024-10-30 | F-1 | F-1 | 0001410578-24-001723 | 333-282904 | 241411284 | 33 | 9464615 | 1 | 1 | |
| 2024-10-23 | 6-K | 6-K | 0001104659-24-110850 | 001-41937 | 241389207 | 34 | 2341680 | |||
| 2024-10-10 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2024-10-10 16:00:00 | 9999999995-24-003158 | 333-282468 | 241366244 | 33 | 1794 | ||
| 2024-10-10 | 424B3 | 424B3 | 0001410578-24-001676 | 333-282468 | 241365790 | 33 | 2834367 | |||
| 2024-10-08 | CORRESP | filename1.htm | 0001104659-24-107036 | 9138 | ||||||
| 2024-10-08 | 6-K | FORM 6-K | 0001104659-24-107034 | 001-41937 | 241360373 | 34 | 130730 | |||
| 2024-10-07 | UPLOAD | filename1.pdf | 0000000000-24-011295 | 333-282468 | 40178 | |||||
| 2024-10-02 | F-1 | F-1 | 0001410578-24-001668 | 333-282468 | 241347319 | 33 | 9592449 | 1 | 1 | |
| 2024-09-20 | 6-K | FORM 6-K | 0001104659-24-101737 | 001-41937 | 241314012 | 34 | 131750 | |||
| 2024-09-13 | 6-K | FORM 6-K | 0001104659-24-099851 | 001-41937 | 241298483 | 34 | 28816 | |||
| 2024-09-05 | 6-K | FORM 6-K | 0001104659-24-097409 | 001-41937 | 241281804 | 34 | 210007 | |||
| 2024-08-30 | 6-K | FORM 6-K | 0001104659-24-095590 | 001-41937 | 241269906 | 34 | 6191228 | |||
| 2024-08-30 | 424B3 | 424B3 | 0001410578-24-001575 | 333-281644 | 241269721 | 33 | 2816210 | |||
| 2024-08-28 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2024-08-28 16:00:00 | 9999999995-24-002671 | 333-281644 | 241258283 | 33 | 1794 | ||
| 2024-08-26 | CORRESP | filename1.htm | 0001104659-24-092790 | 8748 | ||||||
| 2024-08-26 | UPLOAD | filename1.pdf | 0000000000-24-009700 | 333-281644 | 40159 | |||||
| 2024-08-20 | 6-K | FORM 6-K | 0001104659-24-091011 | 001-41937 | 241222526 | 34 | 16300 | |||
| 2024-08-19 | F-1 | F-1 | 0001410578-24-001519 | 333-281644 | 241220471 | 33 | 9538013 | 1 | 1 | |
| 2024-08-19 | 424B3 | 424B3 | 0001410578-24-001505 | 333-276973 | 241218473 | 33 | 3029131 | |||
| 2024-08-15 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001410578-24-001322,2024-08-15 | 9999999995-24-002537 | 333-276973 | 241214029 | 33 | 1807 | ||
| 2024-08-12 | POS AM | POS AM | 0001410578-24-001322 | 333-276973 | 241198012 | 33 | 9539372 | 1 | 1 | |
| 2024-07-31 | 6-K | FORM 6-K | 0001104659-24-084349 | 001-41937 | 241162054 | 34 | 381451 | |||
| 2024-07-31 | S-8 | FORM S-8 | 0001104659-24-084039 | 333-281112 | 241159100 | 33 | 107122 | |||
| 2024-07-29 | 20-F | 20-F | 0001410578-24-001112 | 001-41937 | 241148195 | 34 | 10604580 | 1 | 1 | |
| 2024-07-24 | 6-K | FORM 6-K | 0001104659-24-082356 | 001-41937 | 241138503 | 34 | 77933 | |||
| 2024-07-23 | 6-K | FORM 6-K | 0001104659-24-081889 | 001-41937 | 241134495 | 34 | 127708 | |||
| 2024-07-05 | 6-K | FORM 6-K | 0001104659-24-077897 | 001-41937 | 241101578 | 34 | 25125 | |||
| 2024-06-20 | 6-K | FORM 6-K | 0001104659-24-073390 | 001-41937 | 241056292 | 34 | 123046 | |||
| 2024-06-06 | 6-K | FORM 6-K | 0001104659-24-068912 | 001-41937 | 241023867 | 34 | 122273 | |||
| 2024-05-14 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2024-05-14 16:00:00 | 9999999995-24-001524 | 333-276973 | 24946868 | 33 | 1793 | ||
| 2024-05-13 | CORRESP | filename1.htm | 0001104659-24-060514 | 7481 | ||||||
| 2024-05-10 | F-1/A | F-1/A | 0001410578-24-000708 | 333-276973 | 24932180 | 33 | 10044951 | 1 | 1 | |
| 2024-05-09 | CORRESP | filename1.htm | 0001104659-24-059474 | 10040 | ||||||
| 2024-05-08 | UPLOAD | filename1.pdf | 0000000000-24-005242 | 333-276973 | 42691 | |||||
| 2024-05-07 | F-1/A | F-1/A | 0001410578-24-000598 | 333-276973 | 24919248 | 33 | 10025615 | 1 | 1 | |
| 2024-05-06 | CORRESP | filename1.htm | 0001104659-24-057598 | 14583 | ||||||
| 2024-04-29 | UPLOAD | filename1.pdf | 0000000000-24-004745 | 333-276973 | 46287 | |||||
| 2024-04-18 | CORRESP | filename1.htm | 0001104659-24-048504 | 29875 | ||||||
| 2024-04-18 | F-1/A | F-1/A | 0001410578-24-000510 | 333-276973 | 24852712 | 33 | 10288267 | 1 | 1 | |
| 2024-03-15 | 6-K | FORM 6-K | 0001104659-24-035072 | 001-41937 | 24755874 | 34 | 26310 | |||
| 2024-03-12 | 6-K | FORM 6-K | 0001104659-24-033543 | 001-41937 | 24743491 | 34 | 5748006 | |||
| 2024-02-23 | UPLOAD | filename1.pdf | 0000000000-24-002088 | 333-276973 | 57819 | |||||
| 2024-02-09 | F-1 | FORM F-1 | 0001104659-24-012923 | 333-276973 | 24614927 | 33 | 2342693 | |||
| 2024-02-05 | SC 13D | SC 13D | 0001104659-24-010648 | 005-94325 | 24596131 | 34 | 43846 | |||
| 2024-02-05 | SC 13G | SC 13G | 0001193125-24-023382 | 005-94325 | 24593852 | 34 | 116955 | |||
| 2024-01-31 | 20-F | FORM 20-F | 0001104659-24-008872 | 001-41937 | 24583844 | 34 | 2052238 | |||
| 2024-01-26 | CERT | 8A_Cert_PBM.pdf | 0001354457-24-000035 | 001-41937 | 24563567 | 34 | 139696 | |||
| 2024-01-25 | 8-A12B | 8-A12B | 0001104659-24-006758 | 001-41937 | 24563298 | 34 | 15943 | |||
| 2024-01-23 | 425 | 425 | 0001104659-24-005669 | 36424 | ||||||
| 2024-01-17 | 425 | 425 | 0001104659-24-004219 | 5226339 | ||||||
| 2023-11-15 | 425 | 425 | 0001104659-23-118785 | 23433 | ||||||
| 2023-11-15 | 424B3 | 424B3 | 0001104659-23-118691 | 333-273553 | 231410949 | 33 | 7706813 | |||
| 2023-11-15 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004669 | 63548 | ||||||
| 2023-11-13 | EFFECT | xslEFFECTX01/primary_doc.xml | F-4,,2023-11-13 17:00:00 | 9999999995-23-003290 | 333-273553 | 231401260 | 33 | 1745 | ||
| 2023-11-13 | F-4/A | F-4/A | 0001104659-23-117179 | 333-273553 | 231398359 | 33 | 7765160 | |||
| 2023-11-13 | CORRESP | filename1.htm | 0001104659-23-116851 | 7076 | ||||||
| 2023-11-13 | F-4/A | F-4/A | 0001104659-23-116850 | 333-273553 | 231395804 | 33 | 7771741 | |||
| 2023-11-06 | F-4/A | F-4/A | 0001104659-23-114379 | 333-273553 | 231377674 | 33 | 9618011 | |||
| 2023-11-03 | CORRESP | filename1.htm | 0001104659-23-114381 | 7150 | ||||||
| 2023-10-25 | UPLOAD | filename1.pdf | 0000000000-23-011670 | 42939 | ||||||
| 2023-10-16 | CORRESP | filename1.htm | 0001104659-23-109429 | 31544 | ||||||
| 2023-10-16 | F-4/A | F-4/A | 0001104659-23-109424 | 333-273553 | 231328061 | 33 | 8382753 | |||
| 2023-10-11 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004521 | 64765 | ||||||
| 2023-10-04 | UPLOAD | filename1.pdf | 0000000000-23-010961 | 56155 | ||||||
| 2023-09-20 | CORRESP | filename1.htm | 0001104659-23-102359 | 93168 | ||||||
| 2023-09-20 | F-4/A | F-4/A | 0001104659-23-102356 | 333-273553 | 231267257 | 33 | 8600836 | |||
| 2023-09-04 | UPLOAD | filename1.pdf | 0000000000-23-009752 | 94437 | ||||||
| 2023-08-01 | F-4 | F-4 | 0001104659-23-085974 | 333-273553 | 231129400 | 33 | 8596422 |
One latest value per concept from companyfacts (109 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 2.29M | 2026-03-31 | 2026 | FY | 20-F | 2026-06-22 | 0001213900-26-070607 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 672.56 | 2026-08-19 | F-3 | 2026-08-26 | 0001213900-26-093628 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 672.56 | 2026-08-19 | F-3 | 2026-08-26 | 0001213900-26-093628 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 4.87M | 2026-08-19 | F-3 | 2026-08-26 | 0001213900-26-093628 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-19 | F-3 | 2026-08-26 | 0001213900-26-093628 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-19 | F-3 | 2026-08-26 | 0001213900-26-093628 | |||
| ifrs-full | AccountingProfit | AccountingProfit | USD | 1.01M | 2024-04-01 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | AccrualsClassifiedAsCurrent | AccrualsClassifiedAsCurrent | USD | 104,936 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | AcquisitiondateFairValueOfTotalConsiderationTransferred | AcquisitiondateFairValueOfTotalConsiderationTransferred | USD | 722,033 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | AdjustedWeightedAverageShares | AdjustedWeightedAverageShares | shares | 1.06M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | USD | -36,839 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | USD | -6,296 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | AdjustmentsForDepreciationExpense | AdjustmentsForDepreciationExpense | USD | 2,634 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | USD | 1.66M | 2022-04-01 | 2023-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | AdjustmentsForSharebasedPayments | AdjustmentsForSharebasedPayments | USD | 26,329 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | AdjustmentsForUnrealisedForeignExchangeLossesGains | AdjustmentsForUnrealisedForeignExchangeLossesGains | USD | -3,945 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | Assets | Assets | USD | 12.81M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | AverageForeignExchangeRate | AverageForeignExchangeRate | pure | 0.742 | 2023-04-01 | 2024-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | BalancesWithBanks | BalancesWithBanks | USD | 7.15M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | BasicEarningsLossPerShare | BasicEarningsLossPerShare | USD/shares | -1.88 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | Borrowings | Borrowings | USD | 10.45M | 2024-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | BorrowingsInterestRate | BorrowingsInterestRate | pure | 0.08 | 2024-01-25 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CapitalReserve | CapitalReserve | USD | 9,445 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | USD | 7.15M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents | CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents | USD | -11,227 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | CashFlowsFromUsedInFinancingActivities | CashFlowsFromUsedInFinancingActivities | USD | 7.06M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | CashFlowsFromUsedInInvestingActivities | CashFlowsFromUsedInInvestingActivities | USD | -4.01M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | CashFlowsFromUsedInOperatingActivities | CashFlowsFromUsedInOperatingActivities | USD | -2.03M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | CashTransferred | CashTransferred | USD | 3.50M | 2025-08-15 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | ClosingForeignExchangeRate | ClosingForeignExchangeRate | pure | 0.738 | 2024-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | ComprehensiveIncome | ComprehensiveIncome | USD | -2.00M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | CurrentAssets | CurrentAssets | USD | 7.63M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CurrentDebtInstrumentsIssued | CurrentDebtInstrumentsIssued | USD | 298,368 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CurrentFinancialLiabilitiesAtAmortisedCost | CurrentFinancialLiabilitiesAtAmortisedCost | USD | 61.75M | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | CurrentPrepaidExpenses | CurrentPrepaidExpenses | USD | 258,092 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CurrentPrepayments | CurrentPrepayments | USD | 156,162 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | CurrentProvisions | CurrentProvisions | USD | 303,896 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CurrentRestrictedCashAndCashEquivalents | CurrentRestrictedCashAndCashEquivalents | USD | 47,191 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | CurrentWarrantLiability | CurrentWarrantLiability | USD | 298,368 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncome | DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncome | USD | 101,708 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | USD | 6.17M | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | DepreciationExpense | DepreciationExpense | USD | 2,634 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | DilutedEarningsLossPerShare | DilutedEarningsLossPerShare | USD/shares | -1.88 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | Equity | Equity | USD | 11.87M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | EquityAndLiabilities | EquityAndLiabilities | USD | 12.81M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | EquityAttributableToOwnersOfParent | EquityAttributableToOwnersOfParent | USD | -200,445 | 2023-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | USD | 317,882 | 2023-04-01 | 2024-03-31 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | FinanceCosts | FinanceCosts | USD | 3,715 | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | FinanceIncome | FinanceIncome | USD | 1,554 | 2022-04-01 | 2023-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | FinancialLiabilities | FinancialLiabilities | USD | 644,700 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | FinancialLiabilitiesAtFairValue | FinancialLiabilitiesAtFairValue | USD | 2.53M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | GainsLossesOnChangeInFairValueOfDerivatives | GainsLossesOnChangeInFairValueOfDerivatives | USD | 745,428 | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | USD | -1,528 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss | GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss | USD | 1.72M | 2024-04-01 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | GeneralAndAdministrativeExpense | GeneralAndAdministrativeExpense | USD | 367,070 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalents | IncreaseDecreaseInCashAndCashEquivalents | USD | 1.01M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | IncreaseDecreaseThroughConversionOfConvertibleInstruments | IncreaseDecreaseThroughConversionOfConvertibleInstruments | USD | 3.61M | 2024-04-01 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | IncreaseDecreaseThroughExerciseOfWarrantsEquity | IncreaseDecreaseThroughExerciseOfWarrantsEquity | USD | 42,528 | 2024-04-01 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | IncreaseDecreaseThroughOtherContributionsByOwners | IncreaseDecreaseThroughOtherContributionsByOwners | USD | 1.40M | 2022-04-01 | 2023-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | InterestExpense | InterestExpense | USD | 5,125 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | InvestmentPropertyFairValueUsedAsDeemedCost | InvestmentPropertyFairValueUsedAsDeemedCost | USD | 5.17M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | InvestmentsInAssociates | InvestmentsInAssociates | USD | 5.17M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | IssuedCapital | IssuedCapital | USD | 68.88M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | IssuedCapitalOrdinaryShares | IssuedCapitalOrdinaryShares | USD | 313,628 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | KeyManagementPersonnelCompensation | KeyManagementPersonnelCompensation | USD | 492,342 | 2024-04-01 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | KeyManagementPersonnelCompensationSharebasedPayment | KeyManagementPersonnelCompensationSharebasedPayment | USD | 22,996 | 2024-04-01 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | USD | 469,346 | 2024-04-01 | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | Liabilities | Liabilities | USD | 943,068 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | NotionalAmount | NotionalAmount | USD | 1.25M | 2024-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | NumberOfInstrumentsOtherEquityInstrumentsGranted | NumberOfInstrumentsOtherEquityInstrumentsGranted | shares | 0 | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement | NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement | pure | 4,838 | 2025-04-17 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | Options | 0 | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | NumberOfSharesIssued | NumberOfSharesIssued | shares | 605,789 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | NumberOfSharesOutstanding | NumberOfSharesOutstanding | shares | 605,789 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | OtherComprehensiveIncome | OtherComprehensiveIncome | USD | -101,040 | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | USD | -3,945 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax | OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax | USD | -3,945 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | OtherCurrentReceivables | OtherCurrentReceivables | USD | 174,187 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | OtherIncome | OtherIncome | USD | 2,533 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | OtherReserves | OtherReserves | USD | 347,253 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | OtherShorttermProvisions | OtherShorttermProvisions | USD | 40,926 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | ParValuePerShare | ParValuePerShare | USD/shares | 2,863.22 | 2024-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | ProceedsFromBorrowingsClassifiedAsFinancingActivities | ProceedsFromBorrowingsClassifiedAsFinancingActivities | USD | 1.00M | 2024-04-01 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | ProceedsFromCurrentBorrowings | ProceedsFromCurrentBorrowings | USD | 1.00M | 2024-04-01 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | ProceedsFromIssueOfOrdinaryShares | ProceedsFromIssueOfOrdinaryShares | USD | 60,000 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ProceedsFromIssuingShares | ProceedsFromIssuingShares | USD | 7.06M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ProfessionalFeesExpense | ProfessionalFeesExpense | USD | 1.22M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ProfitLoss | ProfitLoss | USD | -1.99M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ProfitLossBeforeTax | ProfitLossBeforeTax | USD | -2.42M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | PropertyPlantAndEquipment | PropertyPlantAndEquipment | USD | 8,690 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod | PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod | USD | 4.00M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | USD | 228 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | RepaymentsOfBondsNotesAndDebentures | RepaymentsOfBondsNotesAndDebentures | USD | 150,000 | 2023-04-01 | 2024-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | USD | 150,000 | 2023-04-01 | 2024-03-31 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | USD | 672,364 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | RestrictedCashAndCashEquivalents | RestrictedCashAndCashEquivalents | USD | 7.20M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | RetainedEarnings | RetainedEarnings | USD | -58.44M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | RevenueFromInterest | RevenueFromInterest | USD | 103,341 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowed | ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowed | USD | 65,000 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | SalesAndMarketingExpense | SalesAndMarketingExpense | USD | 154,976 | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |
| ifrs-full | ServicesExpense | ServicesExpense | USD | 1.00M | 2023-04-01 | 2024-03-31 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 |
| ifrs-full | TaxEffectOfForeignTaxRates | TaxEffectOfForeignTaxRates | USD | 6,871 | 2024-04-01 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | TaxExpenseIncomeAtApplicableTaxRate | TaxExpenseIncomeAtApplicableTaxRate | USD | 268,124 | 2024-04-01 | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 |
| ifrs-full | TradeAndOtherCurrentPayables | TradeAndOtherCurrentPayables | USD | 858,558 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | TradeAndOtherCurrentPayablesToTradeSuppliers | TradeAndOtherCurrentPayablesToTradeSuppliers | USD | 805,613 | 2024-09-30 | 2025 | Q2 | 6-K | 2025-01-23 | 0001410578-25-000039 | |
| ifrs-full | TradeAndOtherPayablesToTradeSuppliers | TradeAndOtherPayablesToTradeSuppliers | USD | 235,868 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | WarrantLiability | WarrantLiability | USD | 1.17M | 2025-03-31 | 2025 | FY | 20-F | 2025-06-25 | 0001213900-25-057893 | |
| ifrs-full | WarrantReserve | WarrantReserve | USD | 1.07M | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 | |
| ifrs-full | WeightedAverageShares | WeightedAverageShares | shares | 1.06M | 2025-04-01 | 2025-09-30 | 2026 | Q2 | 6-K | 2025-11-20 | 0001213900-25-113106 |